A Prospective Cohort Study of the Effect of Depot Medroxyprogesterone Acetate on Detection of Plasma and Cervical HIV-1 in Women Initiating and Continuing Antiretroviral Therapy

被引：14
|
作者：
Day, Summer [1 ]
Graham, Susan M. [1 ,2 ]
Masese, Linnet N. [3 ]
Richardson, Barbra A. [4 ,5 ,6 ]
Kiarie, James N. [7 ]
Jaoko, Walter [2 ]
Mandaliya, Kishorchandra [8 ]
Chohan, Vrasha [1 ,6 ]
Overbaugh, Julie [6 ]
McClelland, R. Scott [1 ,2 ,3 ,5 ]
机构：
[1] Univ Washington, Dept Med, Seattle, WA 98104 USA
[2] Univ Nairobi, Dept Med Microbiol, Nairobi, Kenya
[3] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA
[4] Univ Washington, Dept Biostat, Seattle, WA 98104 USA
[5] Univ Washington, Dept Global Hlth, Seattle, WA 98104 USA
[6] Fred Hutchinson Canc Res Ctr, Seattle, WA 98104 USA
[7] Univ Nairobi, Dept Obstet & Gynaecol, Nairobi, Kenya
[8] Pathcare Labs, Mombasa, Kenya
来源：
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES | 2014年 / 66卷 / 04期
基金：
美国国家卫生研究院;
关键词：
hormonal contraception; HIV-1; antiretroviral therapy; DMPA; HORMONAL CONTRACEPTION; COMPETING RISKS; TRANSMISSION; ACQUISITION; ADHERENCE; RNA;
D O I：
10.1097/QAI.0000000000000187
中图分类号：
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号：
100102 ;
摘要：
Depot medroxyprogesterone acetate (DMPA) use among HIV-1-infected women may increase transmission by increasing plasma and genital HIV-1 RNA shedding. We investigated associations between DMPA use and HIV-1 RNA in plasma and cervical secretions. One hundred two women initiated antiretroviral therapy, contributing 925 follow-up visits over a median of 34 months. Compared with visits with no hormonal contraception exposure, DMPA exposure did not increase detection of plasma (adjusted odds ratio: 0.81, 95% confidence interval: 0.47 to 1.39) or cervical HIV-1 RNA (adjusted odds ratio: 1.41, 95% confidence interval: 0.54 to 3.67). Our results suggest that DMPA is unlikely to increase infectivity in HIV-positive women who are adherent to effective antiretroviral therapy.
引用
收藏
页码：452 / 456
页数：5
相关论文
共 50 条
  • [1] A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy
    Masese, Linnet N.
    Graham, Susan M.
    Gitau, Ruth
    Peshu, Nobert
    Jaoko, Walter
    Ndinya-Achola, Jeckoniah O.
    Mandaliya, Kishorchandra
    Richardson, Barbra A.
    Overbaugh, Julie
    McClelland, R. Scott
    BMC INFECTIOUS DISEASES, 2011, 11
  • [2] Safety and tolerability of depot medroxyprogesterone acetate among HIV-infected women on antiretroviral therapy: ACTG A5093
    Watts, D. Heather
    Park, Jeong-Gun
    Cohn, Susan E.
    Yu, Song
    Hitti, Jane
    Stek, Alice
    Clax, Pamela A.
    Mudersnach, Laila
    Lertora, Juan J. L.
    CONTRACEPTION, 2008, 77 (02) : 84 - 90
  • [3] A prospective study of vaginal trichomoniasis and HIV-1 shedding in women on antiretroviral therapy
    Linnet N Masese
    Susan M Graham
    Ruth Gitau
    Nobert Peshu
    Walter Jaoko
    Jeckoniah O Ndinya-Achola
    Kishorchandra Mandaliya
    Barbra A Richardson
    Julie Overbaugh
    R Scott McClelland
    BMC Infectious Diseases, 11
  • [4] Changes in Vaginal Microbiota and Immune Mediators in HIV-1-Seronegative Kenyan Women Initiating Depot Medroxyprogesterone Acetate
    Roxby, Alison C.
    Fredricks, David N.
    Odem-Davis, Katherine
    Asbjoernsdottir, Kristjana
    Masese, Linnet
    Fiedler, Tina L.
    De Rosa, Stephen
    Jaoko, Walter
    Kiarie, James N.
    Overbaugh, Julie
    McClelland, R. Scott
    JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2016, 71 (04) : 359 - 366
  • [5] Preexposure prophylaxis is efficacious for HIV-1 prevention among women using depot medroxyprogesterone acetate for contraception
    Heffron, Renee
    Mugo, Nelly
    Were, Edwin
    Kiarie, James
    Bukusi, Elizabeth A.
    Mujugira, Andrew
    Frenkel, Lisa M.
    Donnell, Deborah
    Ronald, Allan
    Celum, Connie
    Baeten, Jared M.
    AIDS, 2014, 28 (18) : 2771 - 2776
  • [6] Effect of acquisition and treatment of cervical infections on HIV-1 shedding in women on antiretroviral therapy
    Gitau, Ruth W.
    Graham, Susan M.
    Masese, Linnet N.
    Overbaugh, Julie
    Chohan, Vrasha
    Peshu, Norbert
    Richardson, Barbra A.
    Jaoko, Walter
    Ndinya-Achola, Jeckoniah O.
    McClelland, R. Scott
    AIDS, 2010, 24 (17) : 2733 - 2737
  • [7] Intramuscular depot medroxyprogesterone acetate accentuates bone loss associated with tenofovir disoproxil fumarate-containing antiretroviral therapy initiation in young women living with HIV (the BONE: CARE study): a prospective cohort study in Uganda
    Matovu, Flavia Kiweewa
    Kiwanuka, Noah
    Nabwana, Martin
    Scholes, Delia
    Musoke, Philippa
    Fowler, Mary Glenn
    Beksinska, Mags E.
    Pettifor, John M.
    Brown, Todd T.
    LANCET GLOBAL HEALTH, 2022, 10 (05): : E694 - E704
  • [8] Effect of HIV-1 and antiretroviral therapy on herpes simplex virus type 2: a prospective study in African women
    Mayaud, P.
    Nagot, N.
    Konate, I.
    Ouedraogo, A.
    Weiss, H. A.
    Foulongne, V.
    Defer, M-C
    Sawadogo, A.
    Segondy, M.
    Van de Perre, P
    SEXUALLY TRANSMITTED INFECTIONS, 2008, 84 (05) : 332 - 337
  • [9] Seminal HIV-1 RNA Detection in Heterosexual African Men Initiating Antiretroviral Therapy
    Mujugira, Andrew
    Coombs, Robert W.
    Heffron, Renee
    Celum, Connie
    Ronald, Allan
    Mugo, Nelly
    Baeten, Jared M.
    JOURNAL OF INFECTIOUS DISEASES, 2016, 214 (02): : 212 - 215
  • [10] Heterosexual HIV-1 transmission after initiation of antiretroviral therapy: a prospective cohort analysis
    Donnell, Deborah
    Baeten, Jared M.
    Kiarie, James
    Thomas, Katherine K.
    Stevens, Wendy
    Cohen, Craig R.
    McIntyre, James
    Lingappa, Jairam R.
    Celum, Connie
    LANCET, 2010, 375 (9731): : 2092 - 2098
12345